Finance

Lists
7780:TPE
Daiken Biomedical Co Ltd
NT$15,75
-0,94%
(-0,15) 1D
20 Okt., 12:18:09 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 7780...
Open
NT$15,75
High
NT$15,85
Low
NT$15,70
Mkt. cap
12,76 mjd
Avg. vol.
827,16 k
Volume
419,02 k
Dividend
8,51%
Quarterly dividend
NT$0,33
Ex-dividend date
03 Sep. 2026
P/E ratio
28,94
52-wk high
NT$29,40
52-wk low
NT$15,65
EPS
NT$0,54
No. of employees
20
Open
NT$15,75
High
NT$15,85
Low
NT$15,70
Mkt. cap
12,76 mjd
Avg. vol.
827,16 k
Volume
419,02 k
Dividend
8,51%
Quarterly dividend
NT$0,33
Ex-dividend date
03 Sep. 2026
P/E ratio
28,94
52-wk high
NT$29,40
52-wk low
NT$15,65
EPS
NT$0,54
No. of employees
20
News stories
From web sources and news partners
About Daiken Biomedical Co Ltd
CEO-
Employees20
Founded2018
Headquarters-
SectorPersonal care products
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
449,32 m
656,11 m
463,84 m
616,34 m
Cost of goods sold
161,39 m
254,83 m
185,10 m
233,80 m
Cost of revenue
161,39 m
254,83 m
185,10 m
233,80 m
Research and development expenses
2,32 m
4,76 m
1,90 m
2,30 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
202,66 m
272,70 m
214,66 m
255,28 m
Operating expense
204,99 m
277,47 m
216,56 m
257,58 m
Total operating expenses
366,38 m
532,29 m
401,67 m
491,38 m
Operating income
82,95 m
123,82 m
62,18 m
124,97 m
Other non operating income
-
113,00 k
629,00 k
68,00 k
EBT including unusual items
86,03 m
152,61 m
140,41 m
169,67 m
EBT excluding unusual items
86,03 m
152,61 m
140,41 m
169,67 m
Income tax expense
16,61 m
27,97 m
36,05 m
43,13 m
Effective tax rate
19,30%
18,33%
25,68%
25,42%
Other operating expenses
-
-
-
-
Net income
69,42 m
124,64 m
104,36 m
126,54 m
Net profit margin
15,45%
19,00%
22,50%
20,53%
Earnings per share
0,11
0,17
-
-
Interest and investment income
2,73 m
22,91 m
38,45 m
45,42 m
Interest expense
-108,00 k
-468,00 k
-827,00 k
-643,00 k
Net interest expenses
2,62 m
22,44 m
37,62 m
44,78 m
Depreciation and amortization charges
-
-
-
-
EBITDA
84,85 m
125,64 m
63,12 m
125,71 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme